In an event held last night at ESADE, the scientist Joan Massagué called on the business and innovation sectors to manifest commitment to the fight against cancer metastasis.
Joan Massagué calls on society to get on board with the challenge posed by metastasis
Cancer metastases slowly unveil their weaknesses
The Severo Ochoa Centres and Maria de Maeztu Units Alliance (SOMMa) aims to promote Spanish science of excellence and safeguard its competitiveness
Yomo 2018: IRB Barcelona presents "La recerca biomèdica des de dins"
From Monday to Wednesday, Barcelona is hosting the scientific conference “Mechanisms of Metastasis”, a
The Severo Ochoa Centres and Maria de Maeztu Units Alliance (SOMMa) brings together research ce
For the second year in a row, IRB Barcelona, in collaboration with BIST (Barcelona Institute of Science and Technology), will participa
Roger Gomis, head of the Growth Control and Cancer Metastasis Lab at IRB Barcelona, participated in the "Càpsules de ciència” video series produced by TV3. In the video he talks about his work on the biology of the metastatic process—research that may contribute to improving patients' lives.
Patrick Aloy, Group Leader of the Structural Bioinformatics and Network Biology Lab at IRB Barcelona participated in the "Càpsules de ciència” video series produced by TV3. In the video he talks about how they apply network biology to find a cure for diseases such as cancer and Alzheimer's.
Carlos Romero is the swimmer behind the "Swim against the current" initiative, which seeks to encourage the general public and companies to support cancer and metastasis research at IRB Barcelona. To mark Father's Day, he sent a message to all parents through RAC1’s programme "Islàndia".
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Felice Alessio Bava
IRB Barcelona Alumni member
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Datos básicos sobre IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.